News FDA OKs First Biodegradable Implant to Lower IOP by Medscape • 2020/03/06 • 0 Comments Bimatoprost implant (Durysta) delivers 10 µg of the prostaglandin analog and is an alternative to daily topical eye drops in patients with open-angle glaucoma or ocular hypertension. FDA Approvals Full Story →